FEB 05, 2014 5:00 PM PST

Veterinary treatment approaches to common clinical signs in toxicology setting

C.E. Credits: CE
Speaker
  • Attending Veterinarian, Director of LAS , National Shanghai Center for New Drug Safety Evaluation & Research (NCDSER), CHINA
    Biography
      Xueying Pan, Director of Laboratory Animal Service, Attending Veterinarian, NCDSER/Shanghai InnoStar Bio-Tech Co., Ltd., Shanghai, China. Received my master degree from Huazhong Agricultural University in Wuhan City, Hubei Province, China. My major was basic veterinary medicine. Now I am a Ph.D candidate in Shanghai Jiaotong University. My major is preventive veterinary medicine. I have been an IACUC member for six years in NCDSER/ Shanghai InnoStar Bio-Tech Co., Ltd. which is a toxicology CRO and majorly conducts GLP preclinical toxicity studies for clients.

    Abstract

    This presentation mainly includes 4 sections, the first one: introduction for CFDA/FDA GLP Regulation and analysis the difference. The second one: introduction of the most important responsibility of veterinarian, for example: to supply support to scientist, to supply veterinary care promptly, to ensure the animal welfare and enrichment. The third one: The procedure for observation of abnormal animal. The fourth one: case for case, for example, alopecia, dehydration, decrease the consumption of food, not drink water, decrease the activity, diarrhea, mass or tumor. Outline - Requirements for animal welfare and veterinary care in related regulations of toxicology study - Requirement for laboratory animals in CFDA GLP regulations - Requirement for laboratory animals in FDA GLP regulations - Requirement for laboratory animals in OECD GLP regulations - Responsibility of veterinarian in the toxicology study - To supply support to scientist - To supply veterinary care promptly - To ensure the animal welfare and enrichment - The procedure for observation of abnormal animal - Case - Alopecia - Dehydration - Decrease the consumption of food, not drink water - Decrease the activity - Diarrhea - Mass or tumor


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    Loading Comments...
    Show Resources